A Phase I/II Randomized Study of the Short-Term Effects of APOMINE Vs Placebo in Postmenopausal Women With Osteoporosis or Low Bone Mass

Trial Profile

A Phase I/II Randomized Study of the Short-Term Effects of APOMINE Vs Placebo in Postmenopausal Women With Osteoporosis or Low Bone Mass

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 24 Aug 2013

At a glance

  • Drugs SR 45023A (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top